Literature DB >> 27138900

Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.

Anura S Indulkar1, Yi Gao2, Shweta A Raina2, Geoff G Z Zhang3, Lynne S Taylor1.   

Abstract

Recent studies on aqueous supersaturated lipophilic drug solutions prepared by methods including antisolvent addition, pH swing, or dissolution of amorphous solid dispersions (ASDs) have demonstrated that when crystallization is slow, these systems undergo liquid-liquid phase separation (LLPS) when the concentration of the drug in the medium exceeds its amorphous solubility. Following LLPS, a metastable equilibrium is formed where the concentration of drug in the continuous phase corresponds to the amorphous solubility while the dispersed phase is composed of a nanosized drug-rich phase. It has been reasoned that the drug-rich phase may act as a reservoir, enabling the rate of passive transport of the drug across a membrane to be maintained at the maximum value for an extended period of time. Herein, using clotrimazole as a model drug, and a flow-through diffusion cell, the reservoir effect is demonstrated. Supersaturated clotrimazole solutions at concentrations below the amorphous solubility show a linear relationship between the maximum flux and the initial concentration. Once the concentration exceeds the amorphous solubility, the maximum flux achieved reaches a plateau. However, the duration for which the high flux persists was found to be highly dependent on the number of drug-rich nanodroplets present in the donor compartment. Macroscopic amorphous particles of clotrimazole did not lead to the same reservoir effect observed with the nanodroplets formed through the process of LLPS. A first-principles mathematical model was developed which was able to fit the experimental receiver concentration-time profiles for concentration regimes both below and above amorphous solubility, providing support for the contention that the nanodroplet phase does not directly diffuse across the membrane but, instead, rapidly replenishes the drug in the aqueous phase that has been removed by transport across the membrane. This study provides important insight into the properties of supersaturated solutions and how these might in turn impact oral absorption through effects on passive membrane transport rates.

Entities:  

Keywords:  liquid−liquid phase separation; membrane transport; reservoir effect; supersaturation

Mesh:

Substances:

Year:  2016        PMID: 27138900     DOI: 10.1021/acs.molpharmaceut.6b00202

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  18 in total

1.  Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Authors:  Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-09-27       Impact factor: 4.200

2.  Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane.

Authors:  Konstantin Tsinman; Oksana Tsinman; Ram Lingamaneni; Saijie Zhu; Bernd Riebesehl; Arnaud Grandeury; Michael Juhnke; Bernard Van Eerdenbrugh
Journal:  Pharm Res       Date:  2018-06-20       Impact factor: 4.200

3.  Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.

Authors:  Anura S Indulkar; Yi Gao; Shweta A Raina; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2018-06-18       Impact factor: 4.200

4.  Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.

Authors:  Anura S Indulkar; Huaping Mo; Yi Gao; Shweta A Raina; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-03-28       Impact factor: 4.200

5.  Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.

Authors:  Clara E Correa Soto; Yi Gao; Anura S Indulkar; Keisuke Ueda; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2022-01-10       Impact factor: 4.200

6.  Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.

Authors:  Anura S Indulkar; Xiaochun Lou; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2022-02-15       Impact factor: 4.200

7.  An Insight into Eudragit S100 Preserving Mechanism of Cinnarizine Supersaturation.

Authors:  Maryam Maghsoodi; Saeideh Mollaie Astemal; Ali Nokhodchi; Hossein Kiaie; Ali Baradar Khoshfetrat; Fatemeh Talebi
Journal:  AAPS PharmSciTech       Date:  2022-03-01       Impact factor: 3.246

8.  Colloidal aggregation: from screening nuisance to formulation nuance.

Authors:  Ahil N Ganesh; Eric N Donders; Brian K Shoichet; Molly S Shoichet
Journal:  Nano Today       Date:  2018-03-10       Impact factor: 20.722

Review 9.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

10.  Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion.

Authors:  Linlin Miao; Yuheng Liang; Wenli Pan; Jingxin Gou; Tian Yin; Yu Zhang; Haibing He; Xing Tang
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.